Why the study?
What are the rates of adverse events and hospital re-admission associated with interscalene catheter insertions for ambulatory shoulder surgery?
What are the rates of adverse events and hospital re-admission associated with interscalene catheter insertions for ambulatory shoulder surgery?
Interscalene catheters for ambulatory shoulder surgery have a low rate of adverse events (6.7%) and hospital readmissions (2.4%), supporting their safe use with appropriate infrastructure and patient selection.
Effective pain therapy after shoulder surgery is the main prerequisite for safe management in an ambulatory setting. We evaluated adverse events and hospital re-admission using a database of 509 interscalene catheters inserted during ambulatory shoulder surgery. Adverse events were recorded for 34 (6.7%) patients (9 (1.8%) catheter dislocations diagnosed in the recovery room, 9 (1.8%) catheter dislocations at home with pain, 2 (0.4%) pain without catheter dislocation, 1 (0.2%) 'secondary' pneumothorax without intervention and 13 (2.6%) other). Twelve (2.4%) patients were re-admitted to hospital (8 (1.6%) for pain, 2 (0.4%) for dyspnoea and 2 (0.4%) for nausea and vomiting), 9 of whom had rotator cuff repair. A well-organised infrastructure, optimally trained medical professionals and appropriate patient selection are the main prerequisites for the safe, effective implementation of ambulatory interscalene catheters in routine clinical practice.
No takes yet. Share an insight, caveat, or question.
Marhofer et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: